Search research articles
Contact Us
Filters
Showing results (211-220 of 334) with videos related to
Page
of 34
Sort By:
Oral Oncology
|
January 25, 2018
HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers
Sara I Pai, J Jack Lee, Thomas E Carey, et al.
Cancer Research
|
October 25, 2011
Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4
Xinhui Wang, Akihiro Katayama, Yangyang Wang, et al.
Cancer Research
|
December 3, 2005
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck
Andreas Albers, Koji Abe, Jennifer Hunt, et al.
Science Translational Medicine
|
March 2, 2018
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
Serena Pellegatta, Barbara Savoldo, Natalia Di Ianni, et al.
Cancer Research
|
April 17, 2010
A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas
William R Burns, Yangbing Zhao, Timothy L Frankel, et al.
Cancer Research
|
September 10, 2009
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition
Jianbo Yang, Matthew A Price, Gui Yuan Li, et al.
International Journal of Oncology
|
December 3, 2011
Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients
Kimitaka Tanaka, Takahiro Tsuchikawa, Masaki Miyamoto, et al.
Journal of Extracellular Vesicles
|
February 22, 2021
Proteomic profile of melanoma cell-derived small extracellular vesicles in patients' plasma: a potential correlate of melanoma progression
Monika Pietrowska, Aneta Zebrowska, Marta Gawin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 23, 2025
B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer
Giulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.
Molecular Cancer
|
March 17, 2025
IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer
Kishu Ranjan, Barani Kumar Rajendran, Imad Ud Deen, et al.
Page
of 34
Search research articles
Search
Showing results (211-220 of 334) with videos related to
Sort By:
Page
of 34
Oral Oncology
|
January 25, 2018
HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers
Sara I Pai, J Jack Lee, Thomas E Carey, et al.
Cancer Research
|
October 25, 2011
Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4
Xinhui Wang, Akihiro Katayama, Yangyang Wang, et al.
Cancer Research
|
December 3, 2005
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck
Andreas Albers, Koji Abe, Jennifer Hunt, et al.
Science Translational Medicine
|
March 2, 2018
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
Serena Pellegatta, Barbara Savoldo, Natalia Di Ianni, et al.
Cancer Research
|
April 17, 2010
A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas
William R Burns, Yangbing Zhao, Timothy L Frankel, et al.
Cancer Research
|
September 10, 2009
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition
Jianbo Yang, Matthew A Price, Gui Yuan Li, et al.
International Journal of Oncology
|
December 3, 2011
Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients
Kimitaka Tanaka, Takahiro Tsuchikawa, Masaki Miyamoto, et al.
Journal of Extracellular Vesicles
|
February 22, 2021
Proteomic profile of melanoma cell-derived small extracellular vesicles in patients' plasma: a potential correlate of melanoma progression
Monika Pietrowska, Aneta Zebrowska, Marta Gawin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 23, 2025
B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer
Giulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.
Molecular Cancer
|
March 17, 2025
IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer
Kishu Ranjan, Barani Kumar Rajendran, Imad Ud Deen, et al.
Page
of 34